Posters
« Back
High-throughput Carbonic Anhydrase Activity and Inhibitor Screening Assays
EP27513
High-throughput Carbonic Anhydrase Activity and Inhibitor Screening Assays
Submitted on 25 Apr 2018

Suratna Hazra, Ph.D., Grigoriy Tchaga, Ph.D., and Gordon Yan, Ph.D.
BioVision Inc
This poster was presented at Experimental Biology 2018
Poster Views: 790
View poster »
Poster Abstract
Carbonic Anhydrase (CA) is a zinc based metalloprotease present in at least 14 different isoforms in mammals. It catalyzes the reversible hydration of carbon dioxide to form bicarbonate and proton, thus playing an important role in pH and CO2 homeostasis. Changes in CA activity are associated with various diseases such as - glaucoma, type II diabetes mellitus, lung, liver diseases etc. As CA is also an important target for cancer therapy, a robust and sensitive high-throughput carbonic anhydrase activity and inhibitor screening assays are very important tools.
Carbonic anhydrase activity or carbon dioxide hydration rate is widely measured by using potentiometer or a stopped-flow instrument as reflected by the change in pH over time. However, this method is not suitable for high-throughput assay. Consequently, in BioVision Inc. we have launched the first high throughput Carbonic Anhydrase Activity Assay Kit, detecting the esterase activity of this enzyme. This kit utilizes the zinc-hydroxide mechanism for carbon dioxide hydration and hydrolysis of an ester substrate resulting in the release of a chromophore signal that is proportional to the enzyme activityReport abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


The efficacy of Autologous Conditioned Serum (ACS) in patients with early osteoarthritis knee
Dr.Madhan Jeyaraman (1), Prof.Ramesh.R (2)

Relationship between Gut microbiota and Parkinson’s disease
Sindhu Sasidhar

Proximal Fibular Osteotomy for medial compartmental knee osteoarthritis - A pilot study
Dr.Madhan Jeyaraman (1), Prof.Ramesh.R (2)

Surgical management of diaphyseal fracture of both bone forearm using TENS in paediatric patients
Dr.Madhan Jeyaraman (1), Prof.Ramesh.R (2)

The MODEL-AD consortium preclinical testing pipeline: pharmacokinetics and pharmacodynamics of prophylactic treatment with levetiracetam on the 5XFAD mouse model of Alzheimer’s Disease
SJ Sukoff Rizzo1, SK Quinney2, KD Onos1, KJ Keezer1, DR Jones2, AR Masters2, IF Metzger2, JA Meyer2, J Peters2, SC Persohn2, BR McCarthy2, AA Riley2, M Sasner1, G Howell1, H Williams1, AJ Oblak2, BL Lamb2, and PR Territo2